Rotavirus VP7 neutralization epitopes of serotype 3 strains. 1989

K Nishikawa, and Y Hoshino, and K Taniguchi, and K Y Green, and H B Greenberg, and A Z Kapikian, and R M Chanock, and M Gorziglia
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892.

Sequence analysis of the gene encoding the major neutralization glycoprotein (VP7) was performed on 27 human and animal rotavirus strains of serotype 3 in order to examine genetic variation within strains of identical serotype. Comparisons of the deduced amino acid sequences of the VP7s showed overall sequence identities of 85% or higher. A higher degree of overall VP7 sequence similarity was observed among strains from the same animal species when compared to strains from different animal species, suggesting that there are species-specific sequences in the VP7 protein. Alignment of the amino acid sequences demonstrated that amino acid sequence divergence among serotype 3 strains from different species was located primarily in previously established VP7 serotype-specific regions where genetic variation was identified among strains of different serotype. These regions were highly conserved among serotype 3 strains derived from the same species. The varying reactivities of three anti-VP7 monoclonal antibodies with the 27 strains was consistent with the occurrence of antigenic variation among serotype 3 strains. Moreover the reactivity of monoclonal antibodies correlated with the amino acid sequence found in two serotype-specific regions (VR5 and VR8). A computer-derived predicted phylogenetic tree suggests that rotavirus strains from different animal species belonging to serotype 3 are more closely related to each other than to rotavirus strains of different serotypes.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D003062 Codon A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). Codon, Sense,Sense Codon,Codons,Codons, Sense,Sense Codons
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005075 Biological Evolution The process of cumulative change over successive generations through which organisms acquire their distinguishing morphological and physiological characteristics. Evolution, Biological
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

K Nishikawa, and Y Hoshino, and K Taniguchi, and K Y Green, and H B Greenberg, and A Z Kapikian, and R M Chanock, and M Gorziglia
January 1991, Archives of virology,
K Nishikawa, and Y Hoshino, and K Taniguchi, and K Y Green, and H B Greenberg, and A Z Kapikian, and R M Chanock, and M Gorziglia
January 1996, Archives of virology,
K Nishikawa, and Y Hoshino, and K Taniguchi, and K Y Green, and H B Greenberg, and A Z Kapikian, and R M Chanock, and M Gorziglia
January 1991, The Journal of general virology,
K Nishikawa, and Y Hoshino, and K Taniguchi, and K Y Green, and H B Greenberg, and A Z Kapikian, and R M Chanock, and M Gorziglia
July 1995, Clinical and diagnostic laboratory immunology,
K Nishikawa, and Y Hoshino, and K Taniguchi, and K Y Green, and H B Greenberg, and A Z Kapikian, and R M Chanock, and M Gorziglia
March 1991, Journal of clinical microbiology,
K Nishikawa, and Y Hoshino, and K Taniguchi, and K Y Green, and H B Greenberg, and A Z Kapikian, and R M Chanock, and M Gorziglia
November 1986, Journal of clinical microbiology,
K Nishikawa, and Y Hoshino, and K Taniguchi, and K Y Green, and H B Greenberg, and A Z Kapikian, and R M Chanock, and M Gorziglia
February 1988, The Journal of general virology,
K Nishikawa, and Y Hoshino, and K Taniguchi, and K Y Green, and H B Greenberg, and A Z Kapikian, and R M Chanock, and M Gorziglia
January 1991, The Journal of general virology,
K Nishikawa, and Y Hoshino, and K Taniguchi, and K Y Green, and H B Greenberg, and A Z Kapikian, and R M Chanock, and M Gorziglia
August 1994, The Journal of general virology,
K Nishikawa, and Y Hoshino, and K Taniguchi, and K Y Green, and H B Greenberg, and A Z Kapikian, and R M Chanock, and M Gorziglia
April 1988, The Journal of general virology,
Copied contents to your clipboard!